Grace TherapeuticsGRCE
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 15 institutions reported holding Grace Therapeutics Inc. (GRCE) in their 13F filings, up 14 from Q3 2024. 13 opened new positions and 0 sold out. The largest holders were ADAR1 Capital Management, LLC ($2.9M), AIGH Capital Management LLC ($2.0M) and Bank of America Corp. ($1.9M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Grace Therapeutics Inc.
- CUSIP
- 00439U104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $4.9M |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 1,314,213 shares bought and 185,936 shares sold, net +1,128,277 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| ADAR1 Capital Management, LLC | 0.62% | Reduce -19.4% | 773,635 | $2.9M |
| AIGH Capital Management LLC | 0.74% | New | 521,083 | $2.0M |
| Bank of America Corp. | 0.00% | New | 494,698 | $1.9M |
| Vanguard Group Inc. | 0.00% | New | 225,000 | $857K |
| Renaissance Technologies | 0.00% | New | 42,975 | $161K |
| Citadel Advisors | 0.00% | New | 23,664 | $90K |
| National Bank of Canada | 0.00% | New | 2,719 | $10K |
| Morgan Stanley | 0.00% | New | 1,882 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,497 | $6K |
| Royal Bank of Canada | 0.00% | New | 546 | $2K |
| Activest Wealth Management | 0.00% | New | 104 | $389 |
| Golden State Wealth Management, LLC | 0.00% | — | 31 | $116 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 28 | $105 |
| JPMorgan Chase & Co. | 0.00% | New | 17 | $65 |
| SBI Securities Co., Ltd. | 0.00% | — | 1 | $4 |
"% of holder's portfolio" is GRCE's weight in each manager's 13F, not the share of Grace Therapeutics Inc. the manager owns.